麦澜德(688273.SH)2025年度归母净利润1.02亿元，同比增长0.47%

Core Viewpoint - The company reported a slight increase in revenue and net profit for the fiscal year 2025, indicating stable performance amidst ongoing investments in brand building and channel optimization [1] Financial Performance - Total revenue for the reporting period reached 432 million yuan, representing a year-on-year growth of 1.66% [1] - Net profit attributable to the parent company was 102 million yuan, showing a year-on-year increase of 0.47% [1] Business Strategy - The company has been focusing on strengthening brand development and optimizing distribution channels to lay a solid foundation for business growth [1] - The reproductive rehabilitation product line maintained a solid competitive advantage in its niche market, achieving steady growth [1] - To consolidate its technological edge and effectively respond to market changes, the company has increased investments in research and development as well as marketing [1]